Full description
This study is a randomized-controlled-trial that aims to assess the efficacy and safety of Zao Ren An Shen (ZRAS) capsule, a Chinese herbal medicine product, for chronic insomnia. After a 1-week placebo run-in, the participants will be randomized to either the experimental group or the placebo group and asked to take three capsule of either ZRAS or placebo every day before bedtime for four weeks. The outcomes will be assessed continuously with a sleep diary and actigraphy, and at baseline, mid-treatement (week 2), post-treatment and follow-up (week 8) with questionnnaires about insomnia severity, fatigue severity, psychological status, and quality of life. The hypothesis is that ZRAS is efficient and safe for chronic insomnia. The dataset relates to the clinical trial ACTRN12619000140156 Investigation of the efficacy and safety of Zao Ren An Shen (ZRAS) capsule for chronic insomnia. This data cannot be shared publicly due to ethics approval conditions. To discuss this data, please contact the NICM Health Research Institute nicm@westernsydney.edu.au.Created: 2025-04-02
Data time period: 04 04 2019 to 28 01 2021
Spatial Coverage And Location
text: Australia
Subjects
ACTRN12619000140156 |
Chinese medicine |
Clinical Health |
Clinical Health Not Elsewhere Classified |
Health |
Health Sciences |
Health Services and Systems |
Health Services and Systems Not Elsewhere Classified |
Traditional Chinese Medicine and Treatments |
Traditional, Complementary and Integrative Medicine |
ZRAS |
clinical trial |
herbal medicine |
insomnia |
sleep |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- DOI : 10.26183/JPRT-8G55
- Local : research-data.westernsydney.edu.au/published/7dbba6d0a56311ef80f129cbcc37d51a
